Using novel murine models of claudin-low and basal-like breast cancer, we tested the hypothesis that diet-induced obesity (DIO) and calorie restriction (CR) differentially modulate progression of these aggressive breast cancer subtypes. on June 23, 2017.
INTRODUCTION
Obesity increases risk and progression of breast cancer in postmenopausal women (1) ; whereas, intentional weight loss or calorie restriction (CR) moderately protects against breast cancer (2, 3) . Breast cancers are multiple distinct diseases, with intrinsic molecular subtypes categorized as basal-like, luminal A, luminal B, triple-negative, claudin-low or Her-2-positive breast cancer (4, 5) . Epidemiological data suggest that the strength of the obesity-breast cancer link varies by intrinsic breast cancer subtype and differentiation status (6) . While obesity is a well-established risk and prognostic factor for the luminal A breast cancer subtype in postmenopausal women (6, 7) , the relationships between dietary energy balance and claudin-low or basal-like breast cancers are not well established, due partially to a paucity of relevant experimental model systems.
Features of claudin-low, and to a lesser extent basal-like, breast tumors include Wnt/β-catenin pathway activation, stem cell-like gene expression and poor morphologic differentiation (4, 8) . The Wnt/β-catenin pathway is associated with the epithelial-tomesenchymal transition (EMT), which is a key developmental program and regulator of tumor-initiating cells (TICs) possessing stem/progenitor cell properties (8) . Links between dietary energy balance and EMT in breast cancer are plausible but remain unclear. TGFβ, a master regulator of EMT, is overexpressed in multiple tissues from obese humans and rodents (9, 10) . SNAIL and TWIST, transcription factors that regulate E-cadherin and trigger EMT, are upregulated in melanoma cells treated in vitro with serum from obese mice (11) . EMT-driven TIC enrichment correlates with hallmarks of cancer progression, including proliferation, angiogenesis, invasion, metastasis, wound healing, and therapeutic resistance (12) . Given the poor prognosis conferred by claudin- 5 low and basal-like breast cancers (6) , identification of mechanistic targets and strategies to prevent or control these breast cancer subtypes is critical.
Here we describe two cell lines that recapitulate claudin-low and basal-like breast tumors, respectively, when orthotopically transplanted into ovariectomized C57BL/6 mice. Ovariectomy was used to mimic the postmenopausal state, which is associated with increased susceptibility to weight gain and breast cancer in women. Both cell lines were 
In vitro characterization of M-Wnt and E-Wnt cell lines
Flow cytometric analysis of CD44 and CD24 cell-surface markers. Cells were grown to 70% confluence in complete media, scraped or trypsinized, and stained with allophycocyanin anti-mouse CD44 and/or phycoerythrin anti-mouse CD24 (BD Biosciences, San Jose, CA) (14, 15) . Rat IgG (BD Biosciences) was used as isotype control (14) . Cell staining was evaluated (4 biological replicates performed on different days) using flow cytometry (FACSCalibur, BD Biosciences), with data from 1x10 4 cells acquired and analyzed (Cell Quest Pro software, BD Biosciences) (14) . 
Molecular characterization of M-Wnt and E-Wnt cell lines or tumors
Microarray gene expression analysis. RNA was purified from M-Wnt and E-Wnt cells using RNeasy mini Kit (Qiagen). Microarray hybridizations were performed as previously described (5) 
Immunostaining
Immunohistochemistry. Immunohistochemical staining was performed as previously described (18) 
Immunofluorescence. Frozen tumor sections embedded in Optimal Cutting
Temperature media were cut (4 μm slices), washed with PBS, fixed in 4% paraformaldehyde, permeabilized (2 minutes) in 0.1% Triton X-100, and neutralized (5 minutes) in 100 mM glycine. Immunofluorescence staining was performed as previously described (19) . Primary antibodies (1:300 dilution; BD Biosciences) included anti-Ecadherin (Catalog #610181), anti-N-cadherin (Catalog #610920), and anti-fibronectin (Catalog #610077). Secondary antibody was FITC-conjugated, donkey anti-mouse IgG 
Effects of energy balance in models of claudin-low and basal-like breast cancer
Upon arrival, 120 ovariectomized, 6-to-8-week-old female C57BL/6 mice (Charles River) were singly housed and randomized (n=40/diet group) to receive one of three dietary regimens for 14 weeks (pelleted diets from Research Diets, Inc.; Table S1 100% of vitamins, minerals, fatty acids and amino acids) of control mice (Table S1 ).
Mice were weighed weekly. 
Statistical Analyses
Summarized data are reported as mean±SEM. Differences were assessed using the unpaired student's t-test (mammosphere size, cellular populations by flow cytometry, relative gene expression), one-way ANOVA followed by Tukey's post-hoc test 
RESULTS

Development of M-Wnt and E-Wnt mammary tumor models
In vitro characterization of M-Wnt and E-Wnt cell lines
The M-Wnt and E-Wnt cell lines, each isolated from a MMTV-Wnt-1 mammary tumor, were characterized for morphology, mammosphere-forming capacity, cell surface expression of CD44 and CD24, ALDH activity, and migration and invasion capability EMT is functionally characterized by a loss of cell-cell adhesion and an increase in migration and invasion (21) . M-Wnt, but not E-Wnt, cells showed migratory capacity in a scratch assay for cell migration ( Figure 1D ). In an invasion chamber assay, M-Wnt cells were significantly more (up to 226-fold) invasive than E-Wnt cells (p<0.001 for assessments at both 18 hours and 30 hours; Figure 1E ).
Tumorigenicity of M-Wnt and E-Wnt cells and biologic features of resultant tumors
To compare the tumorigenicity of (unsorted) M-Wnt and E-Wnt cell lines, cells were orthotopically transplanted into the mammary fat pads of female C57BL/6 mice in a limiting dilution analysis (1x10 7 to 50 cells for M-Wnt, and 5x10 7 to 50 cells for E-Wnt, per animal). Tumors were generated with as few as 50 M-Wnt cells, while at least 5x10 
Molecular characterization of M-Wnt and E-Wnt cells and tumors
In microarray analyses (Figure 3 
Dietary energy balance interventions in orthotopic transplant models of claudin-low (M-Wnt) and basal-like (E-Wnt) breast cancer
Generation of DIO, control, and CR phenotypes
Ovariectomized female C57BL/6 mice administered DIO, control or CR diet regimens manifested 3 distinct phenotypes: obese, control and lean. At 8 weeks, body weights were 32.2±0.04 g in DIO mice (p<0.001 vs control), 25.6±0.03 g in control, and 17.3±0.03 g in CR mice (p<0.001 vs control). Similarly, percent body fat decreased from 42.0±0.05% in DIO mice (p<0.001 vs control) to 26.1±0.05% in control, and to 19.1±0.05% in CR mice (p<0.001 vs control). Significant differences in serum levels of energy balance-related hormones and cytokines after 14 weeks of diet included increased leptin, insulin, resistin, IGF-1, and IL-6 in DIO mice, relative to control (p<0.05 for all); and decreased leptin, insulin, and 17-β estradiol, and increased adiponectin in CR mice, relative to control (p<0.05, each; Figure 5 ). Fasting serum glucose was reduced in CR mice, relative to control mice (p<0.05). 
Effects of DIO and CR, relative to control, on tumor progression
The DIO, control, and CR mice were orthotopically transplanted at 8 
Effects of DIO and CR, relative to control, on EMT
Consistently for both claudin-low (M-Wnt) and basal-like (E-Wnt) tumors, DIO (relative to control) promoted EMT, as evidenced by decreased E-cadherin, and increased fibronectin and N-cadherin protein expression; while CR (relative to control) promoted a shift toward an epithelial phenotype, as evidenced by increased E-cadherin, and We speculate that DIO prepares fertile soil (tumor microenvironment), including changes in EMT, intratumoral adipocytes, and local and systemic hormones, growth factors, and cytokines, for enhanced tumor progression, and that determinants of growth in this fertile soil include the plant variety (intrinsic breast cancer subtype) and/or the seed density (extent of TIC enrichment). In contrast, CR may discourage tumor progression by acting on the soil antithetically to DIO, including promoting epithelial differentiation, discouraging EMT, preventing intratumoral adipocytes, and decreasing systemic hormones, growth factors and cytokines. Future studies are warranted to determine whether the mammary tumor-enhancing effects of DIO depend on the extent of TICenrichment in different subtypes of breast cancer, and whether CR targets different (and perhaps TIC-independent) pathways than DIO to impact breast cancer progression.
The present findings extend our previous reports (30, 32) and are the first (to our knowledge) to establish an effect of dietary energy balance interventions on EMT in mammary cancer. We report that in both M-Wnt and E-Wnt tumors DIO deceases Ecadherin, and increases N-cadherin and fibronectin protein expression, while CR increases E-cadherin expression. DIO in both tumor types also increases expression of several EMT-and TIC-associated genes, including TGFβ, SNAIL, FOXC2, and Oct4, each of which is modulated by obesity-related growth factors (9, 10, 11, 33, 34) . 
